ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes

Journal of Cellular Biochemistry

Volumn 90, Issue 3, 2003, Pages 561-572

  Pagano, Eleonora ^a   Calvo, Juan Carlos ^b  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

3T3 L1 cells; Adipocyte differentiation; CAMP; Dexamethasone; EGF; EGFR; ErbB2; Fibroblasts; Heregulin; Insulin; Tyrosine phosphorylation

Indexed keywords

DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; GROWTH HORMONE; HEREGULIN ALPHA1; HEREGULIN BETA1; METHYLXANTHINE DERIVATIVE; NEU DIFFERENTIATION FACTOR; THYROID HORMONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; MALIGNANT TRANSFORMATION; MITOGENESIS; NONHUMAN; ONCOGENE NEU; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; HUMANS; INSULIN; MICE; NEUREGULIN-1; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0141988841     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10647     Document Type: Article

References (39)

1. Adachi H, Kurachi H, Homma H, Adachi K, Takashi I, Morishige K, Matsuzawa Y, Miyake A. 1994. Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro. Endocrinology 135:1824-1830.
2. Ailhaud G. 1997. Obesity and the adipocyte. Molecular mechanisms of adipocyte differentiation. J Endocr 155:201-202.
3. Balaña ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde P. 2001. Activation of erbB-2 via a hierarchical interaction between erbB-2 and type I insulin-like growth factor receptor in mammary tumor cells. Oncogene 20:34-47.
4. Barbier A, Poppleton H, Yigzaw Y, Mullenix J, Wiepz G, Bertics P, Patel T. 1999. Transmodulation of epidermal growth factor receptor function by cyclic AMP-dependent protein kinase. J Biol Chem 274:14067-14073.
5. Bates NP, Hurst HC. 1997. Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland. J Mammary Gland Biol Neoplasia 2:153-163.
6. Boney CM, Smith RM, Gruppuso PA. 1998. Modulation of insulin-like growth factor 1 mitogenic signaling in 3T3-L1 preadipocyte differentiation. Endocrinology 139:1638-1644.
7. Carraway KL III, Burden SJ. 1995. Neuregulins and their receptors. Curr Opin Neurobiol 5:606-612.
8. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. 1994. A functional insulin-like growth factor 1 receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14(7):4588-4595.
9. Croxtall JD, Choudhury Q, Flower RJ. 2000. Glucocorticoids act within minutes to inhibit recruitment of signaling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130:289-298.
10. Darcy KM, Zangani D, Wohlhueter AL, Huang RY, Vaughan MM, Russell JA, Ip MM. 2000. Changes in erbB2 [her-2/neu], erbB3, and erbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells. J Histochem Cytochem 48:63-80.
11. De Bortoli M, Dati C. 1997. Hormonal regulation of type I receptor tyrosine kinases expression in the mammary gland. J Mammary Gland Biol Neoplasia 2:175-185.
12. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. 1997. ErbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling. EMBO J 16:1647-1655.
13. Green H, Kehinde O. 1974. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113-116.
14. Hardy RW, Gupta KB, McDonals JM, Williford J, Wells A. 1995. Epidermal growth factor (EGF) receptor carboxiterminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes. Endocrinology 136:431-439.
15. Hynes NE, Stern DF. 1994. The biology of erbB-2/HER-2 and its role in cancer. Biochim Biophys Acta 1198:165-184.
16. Junttila TT, Sundvall M, Maatta JA, Elenius K. 2000. ErbB4 and its isoforms: Selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10:304-310.
17. Karlan B, Jones J, Slamon D, Lagasse L. 1994. Glucocorticoids stabilize Her-2/neu messenger RNA in human epithelial ovarian carcinoma cells. Gynecol Oncol 53:421-426.
18. Kim S, Houtman JCD, Jiang J, Ruppert M, Bertics PJ, Frank SJ. 1999. Growth hormone-induced alteration in erbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem 274:36015-36024.
19. Lee H, Maihle N. 1998. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues. Oncogene 16:3243-3252.
20. Lim H, Dey SK, Das SK. 1997. Differential expression of the erbB2 gene in the periimplantation mouse uterus: Potential mediator of signaling by epidermal growth factor-like growth factors. Endocrinology 138:1328-1337.
21. Markogiannakis E, Georgoulias V, Margioris A, Zoumakis E, Stournaras C, Gravanis A. 1997. Estrogens and glucocorticoids induce the expression of c-erbB2/NEU receptor in Ishikawa human endometrial cells. Life Sci 61:1083-1095.
22. Morrison RF, Farmer SR. 2000. Symposium: Adipocyte function, differentiation and metabolism. Hormonal signaling and transcriptional control of adipocyte differentiation. J Nutr 130:3116S-3121S.
23. Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T, Siddle K, O'Rahilly S. 2002. Microarray analysis of insulin and insulin-growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem 277(45):42480-42487.
24. Olayioye MA, Neve R, Lane HA, Hynes NE. 2000. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J 19:3159-3167.
25. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y. 1992. Isolation of the neu/HER-2 stimulatory ligand: A 44 kDa glycoprotein that induces differentiation of mammary tumor cells. Cell 69:205-216.
26. Press MF, Cordon-Cardo C, Slamon DJ. 1990. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953-962.
27. Reed BC, Kaufmann SH, Mackall JC, Student AK, Lane MD. 1977. Alterations in insulin binding accompaying differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 74:4876-4880.
28. Roudabush FL, Pierce KL, Maudsley S, Khan KD, Lutrell LM. 2000. Tansactivation of the EGF receptor mediates IGF-1-stimulated Shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 275:22583-22589.
29. Schmidt W, Pöll-Jordan G, Löffler G. 1990. Adipose convertion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor-1, corticosterone, and cyclic AMP. J Biol Chem 265:15489-15495.
30. Schroeder JA, Lee DC. 1998. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9:451-464.
31. Serrero G. 1987. EGF inhibits the differentiation of adipocyte precursors in primary cultures. Biochem Biophys Res Commun 146:194-202.
32. Serrero G, Mills D. 1991. Physiologic role of EGF on adipose tissue development in vivo. Proc Natl Acad Sci USA 88:3912-3916.
33. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL III. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665.
34. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. 1988. Insulin-like growth factor-1 is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263:9402-9408.
35. Srivinisan R, Leverton K, Sheldon H, Hurst H, Sarraf C, Gullick W. 2001. Intracellular expression of the truncated extracellular domain of c-erbB3/HER3. Cell Signal 13:321-330.
36. Stern DF, Kamps MP. 1988. EGF-stimulated tyrosine phosphorylation of p185neu: A potential model for receptor interactions. EMBO J 7:995-1001.
37. Yao H, Labudda K, Rim C, Loda M, Stork PJ. 1995. Cyclic adenosine monophosphate can convert epidermal growth factor into a differentiating factor in neuronal cells. J Biol Chem 270:20748-20753.
38. Yao H, York RD, Misra-Press A, Carr DW, Stork PJ. 1998. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J Biol Chem 273:8240-8247.
39. Zizola C, Balaña ME, Sandoval M, Calvo JC. 2002. Changes in IGF-1 receptor and IGF-1 mRNA during differentiation of 3T3-L1 preadipocytes. Biochimie 84:975-980.